Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Ukoniq
(umbralisib) /
TG Therap
Welcome,
Profile
Billing
Logout
7 Diseases
4 Trials
4 Trials
1090 News
«
1
2
3
4
5
6
7
8
9
10
11
|||
|||||||
Ukoniq
(umbralisib) /
TG Therap
,
Briumvi
(ublituximab-xiiy) /
TG Therap
New P1 trial, Combination therapy:
Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies
(clinicaltrials.gov) - Dec 8, 2013
P1
, N=100, Recruiting,
Sponsor: TG Therapeutics, Inc.
|||
|||||||
Ukoniq
(umbralisib) /
TG Therap
New P1 trial:
HEMREF 31: Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies
(clinicaltrials.gov) - Jan 10, 2013
P1
, N=60, Recruiting,
Sponsor: TG Therapeutics, Inc.